Intelligence Platform
Patents
Browse 1,157 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.
US 8426379
POT1 alternative splicing variants
granted patentUS 8420620
Induced internalization of surface receptors
granted patentUS 8420107
Peptide vaccines against group A streptococci
granted patentUS 8415456
Substituted IL-15 polypeptides
granted patentUS 8410292
Epoxy-guaiane derivatives and treatment of cancer
granted patentUS 8404818
Monoclonal antibodies against orthopoxviruses
granted patentUS 8404244
Papillomavirus L2 N-terminal peptides for the induction of broadly cross-neutralizing anti
granted patentUS 8399689
Chrysophaentin antimicrobial compounds that inhibit FtsZ protein
granted patentUS 8383817
Benztropine compounds and uses thereof
granted patentUS 8383589
Aegyptin and uses thereof
granted patentUS 8383133
Conjugates of Plasmodium falciparum surface proteins as malaria vaccines
granted patentUS 8383099
Adoptive cell therapy with young T cells
granted patentUS 8354115
CD40 ligand adjuvant for respiratory syncytial virus
granted patentUS 8349586
Commensal strain of E. coli encoding an HIV GP41 protein
granted patentUS 8349888
Phytoestrogenic isoflavone compositions, their preparation and use thereof for protection
granted patentUS 8344019
Methods for the production of biliverdin
granted patentUS 8337831
Live, oral vaccine for protection against Shigella dysenteriae serotype 1
granted patentUS 8337854
Monoclonal antibodies against dengue and other viruses with deletion in Fc region
granted patentUS 8337853
Monoclonal antibodies that bind or neutralize dengue virus
granted patentUS 8337832
Vaccine for protection against Shigella sonnei disease
granted patentUS 8323961
HIV vaccines based on adenoviral vectors encoding Env from multiple clades of HIV
granted patentUS 8318666
Use of leptin to treat metabolic abnormalities associated with lipoatrophy
granted patentUS 8318177
Viral chemokine-antigen fusion proteins
granted patentUS 8309527
Immunomodulatory oligonucleotides
granted